Emma Hickman

1.5k total citations
15 papers, 1.3k citations indexed

About

Emma Hickman is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Emma Hickman has authored 15 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Molecular Biology and 4 papers in Immunology. Recurrent topics in Emma Hickman's work include Cancer-related Molecular Pathways (7 papers), Cell death mechanisms and regulation (5 papers) and CAR-T cell therapy research (3 papers). Emma Hickman is often cited by papers focused on Cancer-related Molecular Pathways (7 papers), Cell death mechanisms and regulation (5 papers) and CAR-T cell therapy research (3 papers). Emma Hickman collaborates with scholars based in United States, United Kingdom and Italy. Emma Hickman's co-authors include Kristian Helin, Francesco Cecconi, Greta Caprara, Heiko Müller, Eros Lazzerini Denchi, Maria Cristina Moroni, Karen H. Vousden, Stewart Bates, Zarin Brown and Emmanuel Xystrakis and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Cell Biology.

In The Last Decade

Emma Hickman

14 papers receiving 1.2k citations

Peers

Emma Hickman
Edison Liu United States
Matthew R. Farren United States
Aleata A. Triplett United States
Luca Pellegrinet United Kingdom
Marieke van de Ven Netherlands
Sha Tian United States
Cynthia Kosinski United States
Emma Hickman
Citations per year, relative to Emma Hickman Emma Hickman (= 1×) peers Evelyne Goillot

Countries citing papers authored by Emma Hickman

Since Specialization
Citations

This map shows the geographic impact of Emma Hickman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Hickman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Hickman more than expected).

Fields of papers citing papers by Emma Hickman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Hickman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Hickman. The network helps show where Emma Hickman may publish in the future.

Co-authorship network of co-authors of Emma Hickman

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Hickman. A scholar is included among the top collaborators of Emma Hickman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Hickman. Emma Hickman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
D’Souza, Deborah N., et al.. (2025). Pediatric Anti-N-methyl-D-aspartate Receptor Encephalitis Presenting With Peripheral Spinal Nerve Root Enhancement. Pediatric Neurology. 172. 134–135.
2.
Hickman, Emma, Martine E. Lomax, & Bent K. Jakobsen. (2016). Antigen Selection for Enhanced Affinity T-Cell Receptor–Based Cancer Therapies. SLAS DISCOVERY. 21(8). 769–785. 12 indexed citations
3.
Rizkallah, P.J., Ruth Simmons, Joseph Dukes, et al.. (2016). Direct molecular mimicry enables off-target cardiovascular toxicity by an enhanced affinity TCR designed for cancer immunotherapy. Scientific Reports. 6(1). 18851–18851. 77 indexed citations
4.
Bot, Adrian, Joanna E. Brewer, Zelig Eshhar, et al.. (2015). Target discovery for T cell therapy: next steps to advance Immunotherapies. Journal for ImmunoTherapy of Cancer. 3(1). 4 indexed citations
6.
Garnett, James P., Emma Hickman, Péter Hegyi, et al.. (2011). Novel Role for Pendrin in Orchestrating Bicarbonate Secretion in Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)-expressing Airway Serous Cells. Journal of Biological Chemistry. 286(47). 41069–41082. 79 indexed citations
7.
Urry, Zoë, Emmanuel Xystrakis, David F. Richards, et al.. (2009). Ligation of TLR9 induced on human IL-10–secreting Tregs by 1α,25-dihydroxyvitamin D3 abrogates regulatory function. Journal of Clinical Investigation. 119(2). 387–98. 154 indexed citations
9.
Hickman, Emma. (2002). The role of p53 and pRB in apoptosis and cancer. Current Opinion in Genetics & Development. 12(1). 60–66. 153 indexed citations
10.
Hickman, Emma & Kristian Helin. (2002). The regulation of APAF1 expression during development and tumourigenesis. APOPTOSIS. 7(2). 167–171. 24 indexed citations
11.
Moroni, Maria Cristina, Emma Hickman, Eros Lazzerini Denchi, et al.. (2001). Apaf-1 is a transcriptional target for E2F and p53. Nature Cell Biology. 3(6). 552–558. 478 indexed citations
12.
Fortin, Andre, Sean P. Cregan, Jason G. MacLaurin, et al.. (2001). APAF1 is a key transcriptional target for p53 in the regulation of neuronal cell death. The Journal of Cell Biology. 155(2). 207–216. 161 indexed citations
13.
Hickman, Emma & Kristian Helin. (2000). The p53 Tumour Suppressor Protein. Biotechnology and Genetic Engineering Reviews. 17(1). 179–212. 11 indexed citations
14.
Bates, Stewart, Emma Hickman, & Karen H. Vousden. (1999). Reversal of p53-induced cell-cycle arrest. Molecular Carcinogenesis. 24(1). 7–14. 14 indexed citations
15.
Hickman, Emma, Stewart Bates, & Karen H. Vousden. (1997). Perturbation of the p53 response by human papillomavirus type 16 E7. Journal of Virology. 71(5). 3710–3718. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026